Round led by Hughes & Company as PatientIQ expands its EHR-integrated network, proprietary benchmarks, and patient reach across additional medical specialties, medical device, and life science companies.

CHICAGO, Sept. 3, 2026 /PRNewswire/ — PatientIQ, the patient outcomes intelligence platform trusted by more than 870 healthcare organizations and 17 million patients across the United States, today announced it has raised $30 million in Series C funding. The round was led by Hughes & Company, a Chicago-based growth equity firm that invests in healthcare software and technology-enabled service companies. Hughes & Company joins current investors: Health Enterprise Partners and August Capital. Travis Hughes, Founder and Managing Partner of Hughes & Company, will join PatientIQ’s Board of Directors.

The financing accelerates PatientIQ’s next phase of growth: deepening its presence across existing specialties and health systems, expanding its real-world evidence platform for medical device and life sciences companies, and building a direct-to-patient commerce experience that connects patients to products and services through its growing marketplace.

“We spent a year studying the patient-reported outcomes space,” said Travis Hughes, Founder and Managing Partner of Hughes & Company. “What we found in PatientIQ is something rare – a company that helped create and define an entirely new category that has a meaningful impact on quality of care. We are excited to be part of PatientIQ’s next chapter of growth.”

Since its Series B in 2022, PatientIQ has grown its EHR-integrated network from 200 healthcare organizations to more than 870, expanded its patient population on the network to over 17 million, and surpassed 70 million patient outcomes collected. The company serves healthcare organizations across more than 20 medical specialties, and powers automated data collection for leading medical device & life science companies, as well as national clinical registries for the American Academy of Orthopaedic Surgeons (AAOS), American Association of Neurological Surgeons (AANS), and Society for Thoracic Surgeons. PatientIQ’s cloud-based platform integrates with more than 50 EHR systems – including Epic, Oracle Cerner, and Athenahealth – automating outcomes capture within existing clinical workflows.

“The reason outcomes data has been so hard to act on in healthcare isn’t a lack of will – it’s a lack of infrastructure,” said Matthew Gitelis, CEO of PatientIQ. “Building that infrastructure, specialty by specialty, workflow by workflow, is what PatientIQ has been doing for a decade. This investment is validation that the approach is working, and the fuel to take it much further.”

The investment comes as CMS expands patient-reported outcome requirements and payers tie reimbursement to demonstrated clinical outcomes. Medical device and life science companies face similar pressure to generate real-world evidence – data that can only come from patients being systematically measured in clinical settings – for regulatory submissions, product differentiation, and post-market surveillance. PatientIQ is positioned to become the standard for outcomes intelligence, connecting the data health systems, researchers, and industry partners need to measure what works and improve care.

About Hughes & Company

Hughes & Company is a private equity firm focused exclusively on investments in software and technology-enabled services within the healthcare sector. The firm aims to partner with companies to drive growth and innovation, pairing strategic guidance and capital to scale solutions that improve patient outcomes and operational efficiency. www.hughes-co.com.

About PatientIQ

PatientIQ is the leading outcomes intelligence platform, trusted by more than 870 healthcare organizations to collect, analyze, and improve patient outcomes. With over 70 million patient-reported outcomes gathered from customers including Northwell Health, Sutter Health, Mercy, Advocate Health, Johnson & Johnson, and Zimmer Biomet, PatientIQ turns the patient voice into actionable insights that drive regulatory compliance, financial performance, and clinical impact. www.patientiq.io

View original content to download multimedia:https://www.prnewswire.com/news-releases/patientiq-raises-30-million-series-c-to-power-the-next-generation-of-patient-reported-outcomes-intelligence-302868502.html

SOURCE PatientIQ